| scholarly article | Q13442814 |
| P8978 | DBLP publication ID | journals/neuroimage/LiLCCHWLS10 |
| P356 | DOI | 10.1016/J.NEUROIMAGE.2009.11.021 |
| P698 | PubMed publication ID | 19931620 |
| P5875 | ResearchGate publication ID | 40025049 |
| P2093 | author name string | Cheng-Ta Li | |
| Jen-Chuen Hsieh | |||
| Tung-Ping Su | |||
| Ching-Po Lin | |||
| Kun-Hsien Chou | |||
| Wei-Chen Lin | |||
| Chia-Liang Wu | |||
| I-Yun Chen | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 347-356 | |
| P577 | publication date | 2009-11-26 | |
| P1433 | published in | NeuroImage | Q1981225 |
| P1476 | title | Structural and cognitive deficits in remitting and non-remitting recurrent depression: a voxel-based morphometric study | |
| P478 | volume | 50 |
| Q39314274 | A Comparison of Neuroimaging Abnormalities in Multiple Sclerosis, Major Depression and Chronic Fatigue Syndrome (Myalgic Encephalomyelitis): is There a Common Cause? |
| Q37054983 | A Meta-Analysis of Executive Dysfunction and Antidepressant Treatment Response in Late-Life Depression |
| Q36745469 | A face a mother could love: depression-related maternal neural responses to infant emotion faces |
| Q42955832 | A subtle grey-matter increase in first-episode, drug-naive major depressive disorder with panic disorder after 6 weeks' duloxetine therapy. |
| Q34542351 | Alterations in regional homogeneity of spontaneous brain activity in late-life subthreshold depression |
| Q92626351 | Alterations of amplitude of low-frequency fluctuation in treatment-resistant versus non-treatment-resistant depression patients |
| Q47802190 | Amygdala and regional volumes in treatment-resistant versus nontreatment-resistant depression patients |
| Q47787298 | Association between change in brain gray matter volume, cognition, and depression severity: Pre- and post- antidepressant pharmacotherapy for late-life depression |
| Q50130902 | Association between increased serum interleukin-6 levels and sustained attention deficits in patients with major depressive disorder |
| Q99371877 | Association between neuromelanin-sensitive MRI signal and psychomotor slowing in late-life depression |
| Q88201556 | Association of Brain Cortical Changes With Relapse in Patients With Major Depressive Disorder |
| Q48397374 | Auditory processing in remitted major depression: a long-term follow-up investigation using 3T-fMRI. |
| Q35120175 | Brain functional changes in facial expression recognition in patients with major depressive disorder before and after antidepressant treatment: A functional magnetic resonance imaging study |
| Q41620947 | Brain grey matter volume alterations associated with antidepressant response in major depressive disorder. |
| Q92141084 | Brain structural effects of treatments for depression and biomarkers of response: a systematic review of neuroimaging studies |
| Q37262684 | Changes of grey matter volume in first-episode drug-naive adult major depressive disorder patients with different age-onset |
| Q58583073 | Choline and N-acetyl aspartate levels in the dorsolateral prefrontal cortex at the beginning of the recovery phase as markers of increased risk for depressive episode recurrence under different duration of maintenance therapy and after it: a retrospe |
| Q30371216 | Chronic stress and brain plasticity: Mechanisms underlying adaptive and maladaptive changes and implications for stress-related CNS disorders |
| Q34345460 | Classification of different therapeutic responses of major depressive disorder with multivariate pattern analysis method based on structural MR scans |
| Q38055516 | Cognitive impairment in euthymic major depressive disorder: a meta-analysis. |
| Q90702027 | Common and distinct abnormal frontal-limbic system structural and functional patterns in patients with major depression and bipolar disorder |
| Q92068365 | Comparative Study of Cognitive Function Between Treatment-Resistant Depressive Patients and First-Episode Depressive Patients |
| Q35917018 | Computational meta-analysis of statistical parametric maps in major depression |
| Q39206756 | Contrasting patterns of deficits in visuospatial memory and executive function in patients with major depression with and without ECT referral |
| Q51155561 | Cortical morphology changes in women with borderline personality disorder: a multimodal approach. |
| Q34849885 | Cortical shape and curvedness analysis of structural deficits in remitting and non-remitting depression |
| Q35124629 | Cortical thickness in youth with major depressive disorder |
| Q37508045 | Cross-Sectional and Longitudinal Relationships between Depressive Symptoms and Brain Atrophy in MS Patients |
| Q48286637 | Differential relations between fronto-limbic metabolism and executive function in patients with remitted bipolar I and bipolar II disorder |
| Q31043772 | Discriminating Bipolar Disorder From Major Depression Based on SVM-FoBa: Efficient Feature Selection With Multimodal Brain Imaging Data |
| Q30465663 | Disentangling depression and distress networks in the tinnitus brain |
| Q48296705 | Efficacy of prefrontal theta-burst stimulation in refractory depression: a randomized sham-controlled study |
| Q92857119 | Examining the Influence of Early Life Stress on Serum Lipid Profiles and Cognitive Functioning in Depressed Patients |
| Q37947201 | Executive dysfunction and treatment response in late-life depression |
| Q37464520 | Frontal-subcortical volumetric deficits in single episode, medication-naïve depressed patients and the effects of 8 weeks fluoxetine treatment: a VBM-DARTEL study |
| Q34565649 | Frontocingulate dysfunction in depression: toward biomarkers of treatment response |
| Q61810333 | Glutamatergic Dysfunction and Glutamatergic Compounds for Major Psychiatric Disorders: Evidence From Clinical Neuroimaging Studies |
| Q33590599 | Gray matter increases in fronto-parietal regions of depression patients with aripiprazole monotherapy: An exploratory study |
| Q37637187 | High dosage of hypnotics predicts subsequent sleep-related breathing disorders and is associated with worse outcomes for depression |
| Q30927398 | In pursuit of neuroimaging biomarkers to guide treatment selection in major depressive disorder: a review of the literature |
| Q35330572 | Increased cognition connectivity network in major depression disorder: a FMRI study |
| Q33933405 | Insular and hippocampal gray matter volume reductions in patients with major depressive disorder. |
| Q34020859 | Longitudinal MRI study of cortical thickness, perfusion, and metabolite levels in major depressive disorder |
| Q89846120 | Lower Choline-Containing Metabolites/Creatine (Cr) Rise and Failure to Sustain NAA/Cr Levels in the Dorsolateral Prefrontal Cortex Are Associated with Depressive Episode Recurrence under Maintenance Therapy: A Proton Magnetic Resonance Spectroscopy |
| Q34370422 | Modulation of interhemispheric functional coordination in electroconvulsive therapy for depression |
| Q47597059 | Neural correlates of social exchanges during the Prisoner's Dilemma game in depression |
| Q48831754 | Neural mechanisms of the cognitive model of depression. |
| Q48789671 | Neuroanatomic correlates of psychogenic nonepileptic seizures: a cortical thickness and VBM study. |
| Q36448359 | Neuromodulation of Attentional Control in Major Depression: A Pilot DeepTMS Study |
| Q44909991 | Neuronal differences between chronic low back pain and depression regarding long-term habituation to pain |
| Q31043230 | Noninvasive brain stimulation treatments for addiction and major depression |
| Q44892036 | Prediction of illness severity in patients with major depression using structural MR brain scans |
| Q55002697 | Prediction of response to drug therapy in psychiatric disorders. |
| Q34486434 | Prefrontal cortical abnormalities in currently depressed versus currently remitted patients with major depressive disorder |
| Q92153497 | Profound and reproducible patterns of reduced regional gray matter characterize major depressive disorder |
| Q47666907 | Progress in Elucidating Biomarkers of Antidepressant Pharmacological Treatment Response: A Systematic Review and Meta-analysis of the Last 15 Years |
| Q90257897 | Promising Neuroimaging Biomarkers in Depression |
| Q38033631 | Psychogenic nonepileptic seizures: a current overview |
| Q41646482 | Reduced GABA neuron density in auditory cerebral cortex of subjects with major depressive disorder. |
| Q48073044 | Regional Coherence Changes in Alzheimer's Disease Patients with Depressive Symptoms: A Resting-State Functional MRI Study |
| Q86982222 | Salience Network Functional Connectivity Predicts Placebo Effects in Major Depression |
| Q48049938 | Smaller hippocampal volumes predict lower antidepressant response/remission rates in depressed patients: A meta-analysis |
| Q48307194 | State-dependent changes in hippocampal grey matter in depression |
| Q35003501 | Structural and cognitive deficits in chronic carbon monoxide intoxication: a voxel-based morphometry study |
| Q35203483 | Surface vulnerability of cerebral cortex to major depressive disorder |
| Q47597246 | The effects of low-dose ketamine on the prefrontal cortex and amygdala in treatment-resistant depression: A randomized controlled study |
| Q30399725 | The neuroscience of depression: implications for assessment and intervention |
| Q34556789 | Towards automated detection of depression from brain structural magnetic resonance images |
| Q37891098 | Triple reuptake inhibitors for treating subtypes of major depressive disorder: the monoamine hypothesis revisited |
Search more.